Kymera Therapeutics Public
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
Connections from
Technology:
Others
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Founded Date:
2017
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Industry:
PharmTech